Viemed Rough ComparisonLooking at Viemed's last quarter for a rough estimate of where PTQ share price could go:
Viemed 2nd Q
Revenue - $22.5 M
Ebitda - $4.6 M
Net Revenue - $1.8 M
Shares Out ~ 38 M
Current Share Price - $10.49
Protech Projected (low end)
Revenue - $95/4 = $23.75 M
Ebitda - $17/4 = $4.25
Shares Out ~ 84 M
Comparable S/P - 38/84 x $10.49 = ~ $4.75
My guess is $2.50 is on the very low end for 12 month targets.